CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 44,796,940 | $16,767,000 | 3.16% |
| Nine Chapters Capital Management LLC | 24,900 | $9,000 | 0.06% |
| FIRST NEW YORK SECURITIES LLC /NY | 53,100 | $19,875,000 | 0.01% |
| JW Asset Management, LLC | 50,254 | $19,000 | 0.01% |
| WASHINGTON TRUST Co | 410,616 | $154,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 919,200 | $344,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 37,284 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 82,880 | $31,000 | 0.00% |
| Modera Wealth Management, LLC | 25,000 | $9,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 526,210 | $195,000 | 0.00% |